For Personal Use. Only Reproduce with Permission the Lancet Publishing Group. Insulin and the Brain Insulin and Neurodegenerative Disease Insulin and Neurodegenerative Disease: Shared and Specific Mechanisms

No abstract is available for this paper.

• Publication year

  year unknown

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Insulin-Degrading Enzyme

  2020cited by this paper
• Diet‐induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease

  2004cited by this paper
• Hyperinsulinemia and risk of Alzheimer disease

  2004cited by this paper
• Degradation of Alzheimer's ß-Amyloid Protein by Human and Rat Brain Peptidases: Involvement of Insulin-Degrading Enzyme

  2004cited by this paper
• Insulin and Insulin-Like Growth Factor I Receptors: Similarities and Differences in Signal Transduction

  2004cited by this paper
• Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function.

  2004cited by this paper
• Prevalence of Dementia in Older Latinos: The Influence of Type 2 Diabetes Mellitus, Stroke and Genetic Factors

  2003cited by this paper
• Epidemiology of the insulin resistance syndrome

  2003cited by this paper
• The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism

  2003cited by this paper
• Insulin degrading enzyme (IDE) genetic variants and risk of Alzheimer's disease: evidence of effect modification by apolipoprotein E (APOE).

  2003cited by this paper
• Prevalence of cerebrovascular lesions in Parkinson's disease. A postmortem study

  2003cited by this paper
• The Endocrine Regulation of Aging by Insulin-like Signals

  2003cited by this paper
• Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction.

  2003cited by this paper
• Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo

  2003cited by this paper
• Insulin Receptor Substrate-2 Deficiency Impairs Brain Growth and Promotes Tau Phosphorylation

  2003cited by this paper
• Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele.

  2003cited by this paper
• Insulin increases CSF Aβ42 levels in normal older adults

  2003cited by this paper
• Potential roles of insulin and IGF-1 in Alzheimer ’ s disease

  2003cited by this paper
• Pathophysiological implications of insulin resistance on vascular endothelial function

  2003cited by this paper
• The aging brain. Changes in the neuronal insulin/insulin receptor signal transduction cascade trigger late-onset sporadic Alzheimer disease (SAD). A mini-review

  2002cited by this paper
• Differential effects of proteases involved in intracellular degradation of amyloid beta-protein between detergent-soluble and -insoluble pools in CHO-695 cells.

  2002cited by this paper
• Genetic variability in the insulin signalling pathway may contribute to the risk of late onset Alzheimer's disease

  2002cited by this paper
• The Relationship between Aβ and Memory in the Tg2576 Mouse Model of Alzheimer's Disease

  2002cited by this paper
• Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study.

  2002cited by this paper
• Endothelium, inflammation, and diabetes

  2002cited by this paper
• Insulin-degrading Enzyme Rapidly Removes the β-Amyloid Precursor Protein Intracellular Domain (AICD)*

  2002cited by this paper
• Insulin/Insulin-like Growth Factor I Hybrid Receptors Have Different Biological Characteristics Depending on the Insulin Receptor Isoform Involved*

  2002cited by this paper
• Polymorphisms of insulin degrading enzyme gene are not associated with Alzheimer's disease.

  2002cited by this paper
• The role of insulin in human brain glucose metabolism: an 18fluoro-deoxyglucose positron emission tomography study.

  2002cited by this paper
• Serum insulin-like growth factor I regulates brain amyloid-β levels

  2002cited by this paper
• Huntington's disease of the endocrine pancreas: insulin deficiency and diabetes mellitus due to impaired insulin gene expression.

  2002cited by this paper
• Insulin resistance and risk for stroke

  2002cited by this paper
• Diabetes Mellitus Is a Risk Factor for Vascular Dementia, but Not for Alzheimer's Disease: A Population-Based Study of the Oldest Old

  2002cited by this paper
• Ablation of Insulin-Producing Neurons in Flies: Growth and Diabetic Phenotypes

  2002cited by this paper
• The influence of diabetes mellitus and hyperglycaemia on stroke incidence and outcome.

  2002cited by this paper
• Confirmation of association between D10S583 and Alzheimer's disease in a case--control sample.

  2002cited by this paper
• Do risk factors for Alzheimer's disease predict dementia in Parkinson's disease? An exploratory study

  2002cited by this paper
• Signalling through IGF-I and insulin receptors: where is the specificity?

  2002cited by this paper
• Soluble oligomers of β amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus

  2002cited by this paper
• Localization and regulation of GLUTx1 glucose transporter in the hippocampus of streptozotocin diabetic rats

  2001cited by this paper
• Vascular parkinsonism: a distinct, heterogeneous clinical entity

  2001cited by this paper
• β-Amyloid-(1–42) Impairs Activity-dependent cAMP-response Element-binding Protein Signaling in Neurons at Concentrations in Which Cell Survival Is Not Compromised*

  2001cited by this paper
• Vascular Parkinsonism: A Review of the Precision and Frequency of the Diagnosis

  2001cited by this paper
• Role of insulin and insulin receptor in learning and memory.

  2001cited by this paper
• Peptide derived from insulin with regulatory activity of dopamine transporter.

  2001cited by this paper
• Insulin receptor substrate protein p53 localization in rats suggests mechanism for specific polyglutamine neurodegeneration.

  2001cited by this paper
• Insulin promotes rapid delivery of N-methyl-d- aspartate receptors to the cell surface by exocytosis

  2001cited by this paper
• Glucose treatment reduces memory deficits in young adult rats fed high-fat diets.

  2001cited by this paper
• Improving Influence of Insulin on Cognitive Functions in Humans

  2001cited by this paper
• Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group.

  2000cited by this paper
• Manipulating neuropeptidergic pathways in humans: a novel approach to neuropharmacology?

  2000cited by this paper
• Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees.

  2000cited by this paper
• Normal cerebrospinal fluid levels of insulin in patients with Parkinson's disease

  2000cited by this paper
• The role of cerebral ischemia in Alzheimer's disease.

  2000cited by this paper
• Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and interrater reliability.

  2000cited by this paper
• Susceptibility locus for Alzheimer's disease on chromosome 10.

  2000cited by this paper
• GLUTX1, a Novel Mammalian Glucose Transporter Expressed in the Central Nervous System and Insulin-sensitive Tissues*

  2000cited by this paper
• Degradation of Soluble Amyloid β-Peptides 1–40, 1–42, and the Dutch Variant 1–40Q by Insulin Degrading Enzyme from Alzheimer Disease and Control Brains

  2000cited by this paper
• Hyperinsulinemia: the missing link among oxidative stress and age-related diseases?

  2000cited by this paper
• Evidence for genetic linkage of Alzheimer's disease to chromosome 10q.

  2000cited by this paper
• Insulin receptors and insulin action in the brain: review and clinical implications.

  2000cited by this paper
• Intracerebroventricular insulin enhances memory in a passive-avoidance task.

  2000cited by this paper
• Intracerebroventricular Administration of Bromocriptine Ameliorates the Insulin-Resistant/Glucose-Intolerant State in Hamsters

  1999cited by this paper
• Insulin Metabolism in Alzheimer’s Disease Differs According to Apolipoprotein E Genotype and Gender

  1999cited by this paper
• The Insulin Receptor Tyrosine Kinase Substrate p58/53 and the Insulin Receptor Are Components of CNS Synapses

  1999cited by this paper
• Type‐2 diabetes and cognitive function in a non‐demented population

  1999cited by this paper
• F2-isoprostane evidence of oxidant stress in the insulin resistant, obese Zucker rat: effects of vitamin E.

  1999cited by this paper
• Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose.

  1999cited by this paper
• Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes.

  1999cited by this paper
• Insulin‐sensitive GLUT4 glucose transporters are colocalized with GLUT3‐expressing cells and demonstrate a chemically distinct neuron‐specific localization in rat brain

  1999cited by this paper
• Effects of posttraining administration of insulin on retention of a habituation response in mice: participation of a central cholinergic mechanism.

  1999cited by this paper
• Longitudinal association of vascular and Alzheimer’s dementias, diabetes, and glucose tolerance

  1999cited by this paper
• Brain Insulin Receptors and Spatial Memory

  1999cited by this paper
• No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans.

  1999cited by this paper
• Characterization of risk factors for vascular dementia

  1999cited by this paper
• Insulin: new roles for an ancient hormone

  1999cited by this paper
• Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease

  1998cited by this paper
• Cognitive Function in an Elderly Population With Persistent Impaired Glucose Tolerance

  1998cited by this paper
• Parkinson's disease. First of two parts.

  1998cited by this paper
• Immunocytochemical localization of the insulin‐responsive glucose transporter 4 (Glut4) in the rat central nervous system

  1998cited by this paper
• Vascular Risks and Incident Dementia: Results from a Cohort Study of the Very Old

  1998cited by this paper
• Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994

  1998cited by this paper
• Insulin-degrading Enzyme Regulates Extracellular Levels of Amyloid β-Protein by Degradation*

  1998cited by this paper
• Blood-to-brain glucose transport and cerebral glucose metabolism are not reduced in poorly controlled type 1 diabetes.

  1998cited by this paper
• Risk of dementia: The Rotterdam Study

  1997cited by this paper
• Risk of dementia among persons with diabetes mellitus: a population-based cohort study.

  1997cited by this paper
• NIDDM and Blood Pressure as Risk Factors for Poor Cognitive Performance: The Framingham Study

  1997cited by this paper
• Association between features of the insulin resistance syndrome and alzheimer's disease independently of apolipoprotein e4 phenotype: cross sectional population based study

  1997cited by this paper
• Transport of insulin across the blood-brain barrier: saturability at euglycemic doses of insulin.

  1997cited by this paper
• Insulin and Insulin-like Growth Factor-1 Regulate Tau Phosphorylation in Cultured Human Neurons*

  1997cited by this paper
• Is Type II Diabetes Associated With an Increased Risk of Cognitive Dysfunction?: A critical review of published studies

  1997cited by this paper
• Insulin gene expression in immortalized rat hippocampal and pheochromocytoma-12 cell lines.

  1997cited by this paper
• Insulin receptor mRNA in the substantia nigra in Parkinson's disease.

  1996cited by this paper
• Diabetes causes differential changes in CNS noradrenergic and dopaminergic neurons in the rat: a molecular study.

  1996cited by this paper
• Diabetes decreases limbic extracellular dopamine in rats.

  1996cited by this paper
• Altered conditioned taste aversion and glucose utilization in related brain nuclei of diabetic GK rats.

  1995cited by this paper
• Four-day hyperinsulinemia in euglycemic conditions alters local cerebral glucose utilization in specific brain nuclei of freely moving rats.

  1995cited by this paper
• Hypothalamic GLUT 4 expression: a glucose- and insulin-sensing mechanism?

  1995cited by this paper
• Short-Term and Long-Term Memory in Elderly Patients with NIDDM

  1995cited by this paper
• Insulin gene expression and insulin synthesis in mammalian neuronal cells.

  1994cited by this paper

• Targeting neuroplasticity in old brain: restoring synapse with cognitive strategies

  2026cites this paper
• Anesthesia-related factors in the pathogenesis of postoperative cognitive dysfunction: a mechanistic perspective

  2026cites this paper
• Long-term fasting insulin variability and cognitive function: Insights from the CARDIA study

  2026cites this paper
• Insulin Signaling in Alzheimer’s Disease: Association with Brain Insulin Resistance

  2026cites this paper
• High-fat diet and cognitive dysfunction: Mechanistic insights into diet-induced neurodegeneration (Review)

  2025cites this paper
• Neurodevelopmental Consequences of Maternal Diabetes: Autophagy and Spatial Arrangement of Hippocampal Neurons

  2025cites this paper
• Astaxanthin: A promising nutraceutical for cardiovascular health

  2025cites this paper
• Cortical surface area as a stronger mediator of the waist-to-height ratio and cognitive impairment link in patients with first-episode schizophrenia compared to body mass index and waist-hip ratio

  2025cites this paper
• Associations Between Diabetes Mellitus and Neurodegenerative Diseases

  2025cites this paper
• The impact of high-sugar diets on central nervous system disorders: mechanisms, pathogenesis, and dietary implication

  2025cites this paper
• Alpha-Lipoic Acid and Metformin Combination Therapy Synergistically Activate Nrf2-AMPK Signaling Pathways to Ameliorate Cognitive Dysfunction in Type 2 Diabetic Encephalopathy: A Preclinical Study

  2025cites this paper
• The Influence of Metabolic Dysfunction-Associated Steatotic Liver Disease and Body Mass Index on the Incidence of Alzheimer Disease: A Nationwide Cohort Study

  2025cites this paper
• Hormonal modulation, mitochondria and Alzheimer’s prevention: the role of GLP-1 agonists and estrogens

  2025cites this paper
• Epigenetic Mediating Mechanisms in Parkinson's Disease: The Impact of Educational Attainment on SETD1A Expression

  2025cites this paper
• The interplay between obesity and triglyceride-glucose index in modulating Parkinson's disease risk: A cross-sectional NHANES study of middle-aged and young adults.

  2025cites this paper
• Intranasal insulin for mild cognitive impairment and Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials.

  2025cites this paper
• Proteomic characterization of plasma exosomes in drug-naïve schizophrenia: Insights into psychosis and cognitive dysfunction.

  2025cites this paper
• Glucose-Lowering Medications, Glycemia, and Cognitive Outcomes: The GRADE Randomized Clinical Trial.

  2025cites this paper
• Parkinson's disease and brain insulin signaling: Mechanisms and potential role of GLP-1 mimetics.

  2025cites this paper
• Nomogram for predicting mild cognitive impairment in Chinese elder CSVD patients based on Boruta algorithm

  2025cites this paper
• Association of waist circumference with all cause mortality in Parkinson’s disease

  2025cites this paper
• Crosstalk of kidney and brain in diabetes-related cognitive impairment and therapeutic strategies

  2025cites this paper
• Ratiometric electrochemical aptasensor with strand displacement for insulin detection in blood samples.

  2024cites this paper
• Age-dependent impact of streptozotocin on metabolic endpoints and Alzheimer's disease pathologies in 3xTg-AD mice.

  2024cites this paper
• Brain responses to intermittent fasting and the healthy living diet in older adults.

  2024cites this paper
• Sex difference in the association between BMI and cognitive impairment in Chinese older adults.

  2024cites this paper
• Association between Parkinson’s disease and cardiovascular disease mortality: a prospective population-based study from NHANES

  2024cites this paper
• The Metabolic Impact of Nonalcoholic Fatty Liver Disease on Cognitive Dysfunction: A Comprehensive Clinical and Pathophysiological Review

  2024cites this paper
• Pharmacological Approaches Using Diabetic Drugs Repurposed for Alzheimer’s Disease

  2024cites this paper
• Association of aging acceleration with serum neurofilament light chain levels: Implications for the roles of modifiable aging factors.

  2024cites this paper
• The Frequency, Predictors and Health Impact of Post-Stroke Extrapyramidal Disorders (Clinical and Epidemiological Study)

  2024cites this paper
• From Liver to Brain: How MAFLD/MASLD Impacts Cognitive Function

  2024cites this paper
• Effects of chronic treatment with metformin on brain glucose hypometabolism and central insulin actions in transgenic mice with tauopathy

  2024cites this paper
• Gut microbiome synthesizes important core metabolites to prevent cognitive decline and mitigate onset and progression of Alzheimer's disease

  2024cites this paper
• Metformin as a Potential Prevention Strategy for Alzheimer’s Disease and Alzheimer’s Disease Related Dementias

  2024cites this paper
• The roles of dietary polyphenols at crosstalk between type 2 diabetes and Alzheimer's disease in ameliorating oxidative stress and mitochondrial dysfunction via PI3K/Akt signaling pathways.

  2024cites this paper
• Association of dietary diversity and weight change with cognitive impairment among Chinese elderly: A prospective national cohort study.

  2024cites this paper
• Protein tyrosine phosphatase receptor type O serves as a key regulator of insulin resistance-induced α-synuclein aggregation in Parkinson’s disease

  2024cites this paper
• Affective and Cognitive Impairments in Rodent Models of Diabetes

  2024cites this paper
• Association of Body Mass Index and Parkinson Disease

  2024cites this paper
• Comprehending the Rationale for Repurposing Type 2 Diabetes Mellitus Medicines for Alzheimer's Disease Patients Via Gene Networks Studies and its Associated Molecular Pathways

  2024cites this paper
• Metabolic-Associated Fatty Liver Disease and Cognitive Performance in Type 2 Diabetes: Basal Data from the Phytate, Neurodegeneration and Diabetes (PHYND) Study

  2024cites this paper
• Fluid dynamics in aging-related dementias

  2023cites this paper
• Neuroprotective Effect of Wharton's Jelly-Derived Mesenchymal Stem Cell-Conditioned Medium (WJMSC-CM) on Diabetes-Associated Cognitive Impairment by Improving Oxidative Stress, Neuroinflammation, and Apoptosis

  2023cites this paper
• Resveratrol-loaded selenium/chitosan nano-flowers alleviate glucolipid metabolism disorder-associated cognitive impairment in Alzheimer's disease.

  2023cites this paper
• Parkinson’s Disease and Type 2 Diabetes Mellitus: Interrelated Pathogenetic Mechanisms and Common Therapeutic Approaches

  2023cites this paper
• Das Exposom im Fokus präventiver Maßnahmen für die Alzheimer- und Parkinson-Erkrankung

  2023cites this paper
• Body Mass Index Decrease Has a Distinct Association with Alzheimer’s Disease Pathophysiology in APOE ɛ4 Carriers and Non-Carriers

  2023cites this paper
• Preliminary screening of Pioglitazone and Diosgenin novel combination for Alzheimer’s disease

  2023cites this paper
• Alterations of the glutamatergic system in diabetes mellitus

  2023cites this paper
• Association between insulin and Nrf2 signalling pathway in Alzheimer's disease: A molecular landscape.

  2023cites this paper
• The development and benefits of metformin in various diseases

  2023cites this paper
• Metabolic slowdown as the proximal cause of ageing and death

  2023cites this paper
• Association of Life's Simple 7 with mild cognitive impairment in community-dwelling older adults in China: a cross-sectional study

  2023cites this paper
• Analysis of the relationship between mild cognitive impairment and serum klotho protein and insulin-like growth factor-1 in the elderly

  2023cites this paper
• Body mass index and two-year change of in vivo Alzheimer’s disease pathologies in cognitively normal older adults

  2023cites this paper
• Intranasal Insulin Delivery: Microparticle Formulations Consisting of Aloe vera Polysaccharides for Advanced Delivery across Excised Olfactory and Respiratory Nasal Epithelial Tissues

  2023cites this paper
• Remote Digital Technologies for the Early Detection and Monitoring of Cognitive Decline in Patients With Type 2 Diabetes: Insights From Studies of Neurodegenerative Diseases

  2023cites this paper
• Synthesis of benzylidene-benzofuranone derivatives as probes for detection of amyloid fibrils in cells

  2023cites this paper
• Metformin restrains ZIKV replication and alleviates virus-induced inflammatory responses in microglia.

  2023cites this paper
• NF‐κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective

  2023cites this paper
• Hyperglycemic crisis and Parkinson disease: A retrospective cohort study based on nationwide data

  2023cites this paper
• The Association of Obesity and Overweight with Executive Functions in Community-Dwelling Older Women

  2023cites this paper
• Potential Role of Metformin in Central Nervous System with a Focus on Its Mechanism of Actions

  2023cites this paper
• The pivotal role of JAK/STAT and IRS/PI3K signaling pathways in neurodegenerative diseases: Mechanistic approaches to polyphenols and alkaloids.

  2023cites this paper
• Is metformin the only culprit for cognitive impairment in diabetes?

  2023cites this paper
• Diet quality and Parkinson’s disease: Potential strategies for non-motor symptom management

  2023cites this paper
• Synthesis of benzylidene-indandione derivatives as quantification of amyloid fibrils.

  2023cites this paper
• The Obesity Paradox: Effect of Body Mass Index and Waist Circumference on Post-Stroke Cognitive Impairment

  2023cites this paper
• Intergenerational Transmission of BMI and Educational Outcomes in Children and Adolescents

  2023cites this paper
• Parkinson’s Disease and Sugar Intake—Reasons for and Consequences of a Still Unclear Craving

  2022cites this paper
• Combined Caloric Restriction and Exercise Provides Greater Metabolic and Neurocognitive Benefits than either as a Monotherapy in Obesity With or Without Estrogen Deprivation.

  2022cites this paper
• Initial BMI and Weight Loss Over Time Predict Mortality in Parkinson Disease.

  2022cites this paper
• Biological and neurological activities of astaxanthin

  2022cites this paper
• Novel insights into non-alcoholic fatty liver disease and dementia: insulin resistance, hyperammonemia, gut dysbiosis, vascular impairment, and inflammation

  2022cites this paper
• Association of Plasma Neurofilament Light Chain With Glycaemic Control and Insulin Resistance in Middle-Aged Adults

  2022cites this paper
• Influence of Genetic and Cardiometabolic Risk Factors in Alzheimer's Disease.

  2022cites this paper
• Potential Roles of Glucagon-Like Peptide-1 and Its Analogues in Dementia Targeting Impaired Insulin Secretion and Neurodegeneration

  2022cites this paper
• Induction of Brain Insulin Resistance and Alzheimer’s Molecular Changes by Western Diet

  2022cites this paper
• Convergent Molecular Pathways in Type 2 Diabetes Mellitus and Parkinson’s Disease: Insights into Mechanisms and Pathological Consequences

  2022cites this paper
• A Bioinformatics Approach Toward Unravelling the Synaptic Molecular Crosstalk Between Alzheimer’s Disease and Diabetes

  2022cites this paper
• Self‐reported diabetes is associated with allocentric spatial processing in the European Prevention of Alzheimer's Dementia Longitudinal Cohort Study

  2022cites this paper
• Insulin Enhances Gene Expression of Midnolin, a Novel Genetic Risk Factor for Parkinson’s Disease, via Extracellular Signal-Regulated Kinase, Phosphoinositide 3-Kinase and Multiple Transcription Factors in SH-SY5Y Cells

  2022cites this paper
• Diabetes Exacerbates Sepsis-Induced Neuroinflammation and Brain Mitochondrial Dysfunction

  2022cites this paper
• Astrocytes as Key Regulators of Brain Energy Metabolism: New Therapeutic Perspectives

  2022cites this paper
• Mitochondrial DNA Copy Number Is Associated With Treatment Response and Cognitive Function in Euthymic Bipolar Patients Receiving Valproate

  2022cites this paper
• Socioeconomic status, BMI, and brain development in children

  2022cites this paper
• Posttranscriptional Regulation of Insulin Resistance: Implications for Metabolic Diseases

  2022cites this paper
• Occurrence of mild cognitive impairment with hyperinsulinaemia in Africans with advanced type 2 diabetes mellitus

  2022cites this paper
• Chronic Intermittent Ethanol Exposure Alters Behavioral Flexibility in Aged Rats Compared to Adult Rats and Modifies Protein and Protein Pathways Related to Alzheimer’s Disease

  2022cites this paper
• [Parkinson's disease and type 2 diabetes mellitus: interrelation of pathogenetic mechanisms and general therapeutic approaches].

  2022cites this paper
• Challenges of repurposing tetracyclines for the treatment of Alzheimer’s and Parkinson’s disease

  2022cites this paper
• Type 2 Diabetes Mellitus and Alzheimer’s Disease: Shared Molecular Mechanisms and Potential Common Therapeutic Targets

  2022cites this paper
• Ketogenic diets and Ketone suplementation: A strategy for therapeutic intervention

  2022cites this paper
• Association between Parkinson’s Disease and Diabetes Mellitus: From Epidemiology, Pathophysiology and Prevention to Treatment

  2022cites this paper
• Crosstalk between neurological, cardiovascular, and lifestyle disorders: insulin and lipoproteins in the lead role

  2022cites this paper
• Body Mass Index, Abdominal Adiposity, and Incidence of Parkinson Disease in French Women From the E3N Cohort Study

  2022cites this paper
• Frontotemporal Dementia and Glucose Metabolism

  2022cites this paper
• Use of Ferulic Acid in the Management of Diabetes Mellitus and Its Complications

  2022cites this paper
• The role of transforming growth factor β1 /Smad pathway in Alzheimer’s disease inflammation pathology

  2022cites this paper